Australia To Make eCTD Mandatory From 2020
Executive Summary
The Therapeutic Goods Administration plans to make the electronic CTD format mandatory for all prescription drug submissions from July 2020, saying this will reduce the time and cost involved in making and evaluating regulatory submissions and bring Australia into line with other international regulators.
You may also be interested in...
Industry Welcomes Mandatory eCTD In Australia, But With Caveats
The Australian regulator, TGA, is currently assessing responses to last year’s consultation on the mandatory use of the eCTD for prescription drug submissions. Industry is mostly happy with the proposal, but has some concerns over the implementation process and certain technical issues.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.